Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes

被引:268
|
作者
de Bie, P.
Muller, P.
Wijmenga, C.
Klomp, L. W. J.
机构
[1] Univ Med Ctr, Lab Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands
[2] Univ Med Ctr, DBG, Dept Med Genet, Complex Genet Sect, NL-3584 EA Utrecht, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
关键词
D O I
10.1136/jmg.2007.052746
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The trace metal copper is essential for a variety of biological processes, but extremely toxic when present in excessive amounts. Therefore, concentrations of this metal in the body are kept under tight control. Central regulators of cellular copper metabolism are the copper-transporting P-type ATPases ATP7A and ATP7B. Mutations in ATP7A or ATP7B disrupt the homeostatic copper balance, resulting in copper deficiency ( Menkes disease) or copper overload ( Wilson disease), respectively. ATP7A and ATP7B exert their functions in copper transport through a variety of interdependent mechanisms and regulatory events, including their catalytic ATPase activity, copper-induced trafficking, post-translational modifications and protein - protein interactions. This paper reviews the extensive efforts that have been undertaken over the past few years to dissect and characterise these mechanisms, and how these are affected in Menkes and Wilson disease. As both disorders are characterised by an extensive clinical heterogeneity, we will discus how the underlying genetic defects correlate with the molecular functions of ATP7A and ATP7B and with the clinical expression of these disorders.
引用
收藏
页码:673 / 688
页数:16
相关论文
共 50 条
  • [31] Molecular mechanisms of copper metabolism and the role of the Menkes disease protein
    Harrison, MD
    Dameron, CT
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 1999, 13 (02) : 93 - 106
  • [32] The copper-transporting ATPases defective in Menkes disease and Wilson disease
    Cox, DW
    THERAPEUTICS USES OF TRACE ELEMENTS, 1996, : 411 - 419
  • [33] Menkes disease: importance of diagnosis with molecular analysis in the neonatal period
    de Athayde Costa, Larissa Sampaio
    Pegler, Stephanie Pucci
    Lellis, Rute Facchini
    Jornada Krebs, Vera Lucia
    Robertson, Stephen
    Morgan, Tim
    Honjo, Rachel Sayuri
    Bertola, Debora Romeo
    Kim, Chong Ae
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2015, 61 (05): : 407 - 410
  • [34] Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations
    Li, Xin-Hua
    Lu, Yi
    Ling, Yun
    Fu, Qing-Chun
    Xu, Jie
    Zang, Guo-Qing
    Zhou, Feng
    Yu, De-Min
    Han, Yue
    Zhang, Dong-Hua
    Gong, Qi-Ming
    Lu, Zhi-Meng
    Kong, Xiao-Fei
    Wang, Jian-She
    Zhang, Xin-Xin
    BMC MEDICAL GENETICS, 2011, 12
  • [35] Molecular correlates of epilepsy in early diagnosed and treated Menkes disease
    Kaler, Stephen G.
    Liew, Clarissa J.
    Donsante, Anthony
    Hicks, Julia D.
    Sato, Susumu
    Greenfield, Jacquelyn C.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (05) : 583 - 589
  • [36] CLINICAL AND MOLECULAR CHARACTERIZATION OF WILSON'S DISEASE IN MOLDOVA: IDENTIFICATION OF 3 NOVEL MUTATIONS
    Mocanu, N.
    Sirocova, N.
    Scvortova, E.
    Todorov, T.
    Zibert, A.
    Schmidt, H.
    Sacara, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 556 - 556
  • [37] Metabolic and molecular bases of Menkes disease and occipital horn syndrome
    Kaler, SG
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 1998, 1 (01) : 85 - 98
  • [38] Molecular Pathogenesis of Legionnaire's Disease
    Higa, Futoshi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S41 - S41
  • [39] Molecular pathogenesis of Alzheimer's disease
    Iwatsubo, T
    INTERNAL MEDICINE, 2003, 42 (03) : 312 - 312
  • [40] Molecular pathogenesis of Parkinson's disease
    Gandhi, S
    Wood, NW
    HUMAN MOLECULAR GENETICS, 2005, 14 (18) : 2749 - 2755